- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ARDS (Moderate or Severe)
Total 1155 results
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasTerminatedModerate to Severe Atopic DermatitisUnited States
-
Technische Universität DresdenCompletedModerate to Severe Atopic DermatitisGermany
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
Keymed Biosciences Co.LtdRecruiting
-
Technische Universität DresdenRecruitingModerate-to-severe Atopic DermatitisGermany
-
Inmagene LLCTerminatedAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Galderma R&DWithdrawn
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
Guy's and St Thomas' NHS Foundation TrustPfizerUnknownModerate and Severe Haemophilia
-
Qurient Co., Ltd.CompletedModerate to Severe Atopic DermatitisUnited States
-
University of MinnesotaNot yet recruitingCovid19 | ARDS | SARS-CoV Infection | ARDS, HumanUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
medac GmbHNot yet recruitingModerate to Severe Atopic Dermatitis
-
Guangzhou JOYO Pharma Co., LtdChengdu JOYO pharma Co., Ltd.Not yet recruitingModerate-to-severe Atopic Dermatitis
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling by invitationModerate to Severe Atopic DermatitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisUnited States, Australia, China, New Zealand
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Royal Victoria InfirmaryBritish Skin FoundationCompletedModerate to Severe Atopic EczemaUnited Kingdom
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingAcute Respiratory Distress Syndrome | COVID-19 Pneumonia | ARDS (Moderate or Severe)United States
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnSevere or Mild Toxicity From Radiotherapy and/or ChemotherapyUnited States
-
Alliance for International Medical ActionBien Être de La femme et de L'Enfant au NigerCompletedMalnutrition | Kwashiorkor | Marasmus | Malnutrition; Degree, ModerateNiger
-
QRxPharma Inc.CompletedModerate to Severe Postoperative PainUnited States
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)Germany
-
Hoffmann-La RocheActive, not recruitingSevere Hemophilia A | Moderate Hemophilia ABrazil, Germany, Italy, Spain, United States, Turkey, United Kingdom, Tunisia, Canada, Hungary, Morocco, Serbia
-
NoblewellMedical Research Agency, Poland; Leszek Giec Upper-Silesian Medical Centre...TerminatedPatients With Moderate or Severe COVID-19Poland
-
Northern State Medical UniversityCompletedARDS, Human | Sepsis, SevereRussian Federation
-
Assistance Publique - Hôpitaux de ParisThe Paul Bennetot FoundationCompletedModerate to Severe DementiaFrance
-
McMaster UniversityCenter for Medicinal Cannabis ResearchNot yet recruitingCannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe
-
Merz North America, Inc.Merz Pharmaceuticals GmbHCompletedModerate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)United States
-
AcelRx Pharmaceuticals, Inc.CompletedAcute Moderate-to-severe PainUnited States
-
Grünenthal GmbHDepomedTerminatedModerate to Severe Acute Postoperative PainUnited States, United Kingdom, Poland
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical TrialsCompletedModerate to Severe Acute Lower Back PainUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate to Severe Psoriasis | Generalized Pustular Psoriasis and Erythrodermic PsoriasisJapan
-
MallinckrodtCompletedMild or Moderate Surgical BleedingUnited States, Netherlands, United Kingdom, Belgium
-
AstraZenecaCompletedModerate/Severe AsthmaRomania
-
Regeneron PharmaceuticalsSanofiRecruitingModerate-to-Severe Atopic Dermatitis | Atopic EczemaUnited States
-
Central Hospital, Nancy, FranceCompletedARDS Due to Severe Acute Respiratory Syndrome Coronavirus 2France
-
Yonsei UniversityRecruitingModerate to Severe Dry EyeKorea, Republic of